Superseded public profile

Not FDA-approved↗Safety records↗

Superseded · version 1: MOTS-c↗

Related names recorded in this version: MOTS-C↗

A mitochondrial-derived peptide included in an FDA compounding-risk record.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

What this version reported

FDA's compounding-risk page says it has not identified human exposure data for drug products containing MOTS-c and lacks important safety information.↗

Organizations named in cited records:
  • U.S. Food and Drug Administration↗

Sources for this version

  1. 1
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026